Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents	$ 2,616.9	$ 4,582.1
Short-term investments	888.7	1,456.5
Accounts receivable, net of allowances of $41.8 (2017) and $40.3 (2016)	4,017.2	4,029.4
Other receivables	596.7	736.9
Inventories	4,035.1	3,561.9
Prepaid expenses and other	821.6	734.6
Total current assets	12,976.2	15,101.4
Other Assets
Investments	5,297.7	5,207.5
Goodwill	4,188.0	3,972.7
Other intangibles, net	4,716.7	4,357.9
Sundry	2,020.2	1,913.8
Total other assets	16,222.6	15,451.9
Property and Equipment
Land, buildings, equipment, and construction in progress	17,136.6	16,777.6
Accumulated depreciation	(8,711.1)	(8,525.0)
Property and equipment, net	8,425.5	8,252.6
Total assets	37,624.3	38,805.9
Current Liabilities
Short-term borrowings and current maturities of long-term debt	2,609.3	1,937.4
Accounts payable	1,220.1	1,349.3
Employee compensation	566.5	896.9
Sales rebates and discounts	3,697.5	3,914.9
Dividends payable	0.0	548.1
Income taxes payable	122.0	119.1
Other current liabilities	2,232.6	2,220.9
Total current liabilities	10,448.0	10,986.6
Other Liabilities
Long-term debt	7,637.5	8,367.8
Accrued retirement benefits	2,455.7	2,453.9
Long-term income taxes payable	697.2	688.9
Other noncurrent liabilities	2,282.2	2,228.2
Total other liabilities	13,072.6	13,738.8
Eli Lilly and Company Shareholders' Equity
Common stock	690.0	688.5
Additional paid-in capital	5,617.6	5,640.6
Retained earnings	15,876.7	16,046.3
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss	(5,064.3)	(5,274.0)
Cost of common stock in treasury	(75.8)	(80.5)
Total Eli Lilly and Company shareholders' equity	14,031.0	14,007.7
Noncontrolling interests	72.7	72.8
Total equity	14,103.7	14,080.5
Total liabilities and equity	$ 37,624.3	$ 38,805.9